Benzos or Barbs? Controversies in Management of Alcohol Withdrawal Syndrome

Alcohol withdrawal syndrome (AWS), often managed in the ICU, can require a coordinated, multiprofessional approach to reduce the morbidity and mortality of severe withdrawal. This SCCM webcast will explore best practices in the management of severe AWS, including the role of benzodiazepines versus barbiturates, adjunctive therapies, and predictive scoring systems for managing high-risk patients outside the ICU.

Participants can earn 1 accredited continuing education (ACE) credit and maintenance of certification (MOC) point.

Tuesday, June 10, 2025
11:00 a.m. – 12:00 p.m. Central Time

Register Now

Learning objectives:

• Appraise current research on benzodiazepine versus barbiturate therapy for severe alcohol withdrawal syndrome (AWS)
• Describe current adjunctive therapies available in the ICU for severe AWS and assess data on their helpfulness for patient-centered outcomes
• Compare sedation scales used in the management of AWS, and describe predictive scores that identify those at high risk who may need ICU admission